PF708

teriparatide biosimilar · Pfenex, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF708, covering 2016-08-04 to 2018-05-23. Get the full timeline:

Most recent: Clinical Trial Update: A Comparison of PF708 and Forteo in Osteoporosis Patients [Phase 3]